Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-99.13%Return on Equity
VS
Market
Sector
Industry
History
$ 0.37Close
$ 0.29 - $ 4.28 52-Week Range
Ticker Information
Ticker
VYNECompany Name
VYNE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQVYNE THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VYNE - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 38.88M | $ -38.55M | -99.13% |
| 3/31/2025 | $ 44.13M | $ -42.2M | -95.61% |
| 12/31/2024 | $ 52.09M | $ -39.83M | -76.48% |
| 9/30/2024 | $ 63.54M | $ -34M | -53.51% |
| 6/30/2024 | $ 74.87M | $ -28.43M | -37.97% |
| 3/31/2024 | $ 83.37M | $ -29.08M | -34.88% |
| 12/31/2023 | $ 88.73M | $ -28.45M | -32.06% |
| 9/30/2023 | $ 11.51M | $ -32.21M | -279.96% |
| 6/30/2023 | $ 17.27M | $ -35.08M | -203.13% |
| 3/31/2023 | $ 26.43M | $ -33.5M | -126.75% |
Key Performance Insights, Last 5 Years
- VYNE THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at -512.73%.
- Over the past 5 years, VYNE THERAPEUTICS INC's average ROE has been -159.96%.
- The median ROE for VYNE THERAPEUTICS INC during this period was -97.37%
- VYNE THERAPEUTICS INC reached its highest ROE over the past 5 years at -32.06%.
- The lowest ROE recorded by VYNE THERAPEUTICS INC in the same timeframe -681.64%
VYNE THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for VYNE THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -253.88M ] / Equity [ $ 49.52M ]
(=) ROE [ -512.73% ] VYNE - Return on Equity, Last 5 years
-681.64%
Minimum
Dec 31, 2020
-32.06%
Maximum
Dec 31, 2023
-159.96%
Average
-97.37%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |